General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 1,000 $ 22,749,000 $ (28,540,000) $ (5,790,000)
Balance, shares at Dec. 31, 2017 7,941,235      
Common stock issued upon exercise of warrants 22,000 22,000
Common stock issued upon exercise of warrants, shares 1,074,921      
Common stock issued upon exercise of options 34,000 $ 34,000
Common stock issued upon exercise of options, shares 32,508     32,508
Proceeds from sale of common stock 2,979,000 $ 2,979,000
Proceeds from sale of common stock, shares 1,163,938      
Fair value of warrants issued for debt extension 1,188,000 1,188,000
Fair value of common stock issued for services 1,546,000 1,545,000
Fair value of common stock issued for services, shares 319,346      
Fair value of common stock issued upon conversion of debt 3,066,000 3,066,000
Fair value of common stock issued upon conversion of debt, shares 1,243,189      
Fair value of common stock upon issuance of convertible debt 595,000 595,000
Fair value of common stock upon issuance of convertible debt, shares 96,667      
Fair value of common stock issued upon conversion of accrued expenses 582,000 582,000
Fair value of common stock issued upon conversion of accrued expenses, shares 27,148      
Common stock issued upon exercise of put option 1,000,000 1,000,000
Common stock issued upon exercise of put option, shares 203,207      
Fair value of vested stock options 1,870,000 1,870,000
Fair value of vested stock options, shares      
Sale of common stock from private placement 2,979,000 2,979,000
Sale of common stock from private placement, shares 1,163,938      
Stock repurchase (20,000) (20,000)
Stock repurchase, shares (46,668)      
Net loss (12,127,000) (12,127,000)
Balance at Dec. 31, 2018 $ 1,000 35,611,000 (40,667,000) (5,055,000)
Balance, shares at Dec. 31, 2018 12,055,491      
Common stock issued upon exercise of warrants
Common stock issued upon exercise of warrants, shares 148,714      
Fair value of common stock issued for services 388,000 388,000
Fair value of common stock issued for services, shares 39,998      
Fair value of common stock upon issuance of convertible debt 128,000 128,000
Fair value of common stock upon issuance of convertible debt, shares 16,667      
Fair value of vested stock options 463,000 463,000
Fair value of vested stock options, shares      
Beneficial holder round up
Beneficial holder round up, shares 83,581      
Net loss (3,008,000) (3,008,000)
Balance at Mar. 31, 2019 $ 1,000 36,590,000 (43,675,000) (7,084,000)
Balance, shares at Mar. 31, 2019 12,344,451      
Balance at Dec. 31, 2018 $ 1,000 35,611,000 (40,667,000) (5,055,000)
Balance, shares at Dec. 31, 2018 12,055,491      
Common stock issued upon exercise of warrants 45,000 $ 45,000
Common stock issued upon exercise of warrants, shares 189,237      
Common stock issued upon exercise of options, shares        
Proceeds from sale of common stock         $ 1,195,000
Proceeds from sale of common stock, shares         598,286
Fair value of common stock issued for services 1,778,000 $ 1,778,000
Fair value of common stock issued for services, shares 1,015,981      
Sale of common stock from private placement         $ 1,195,000
Sale of common stock from private placement, shares         598,286
Fair value of warrants issued to Series A Preferred stockholders (2,400,000) $ (2,400,000)
Sale of common stock from Public Offering $ 1,000 18,362,000 18,363,000
Sale of common stock from Public Offering, shares 6,549,596      
Fair value of common stock issued for acquisition 7,820,000 7,820,000
Fair value of common stock issued for acquisition, shares 3,327,791      
Fair value of common stock issued to settle accounts payable 10,000 10,000
Fair value of common stock issued to settle accounts payable, shares 4,142      
Fair value of common stock and warrants issued to settle notes payable 1,410,000 1,410,000
Fair value of common stock and warrants issued to settle notes payable, shares 598,286      
Conversion of convertible debt 410,000 410,000
Conversion of convertible debt, shares 182,333      
Common stock upon issuance of convertible debt 182,000 182,000
Common stock upon issuance of convertible debt, shares 25,272      
Issuance of fractional shares due to reverse split
Issuance of fractional shares due to reverse split, shares 139,036      
Issuance of Series A convertible preferred stock for cash 4,688,000 4,688,000
Issuance of Series A convertible preferred stock for cash, shares 5,030        
Conversion of series A preferred shares
Conversion of series A preferred shares, shares (634) 409,032      
Fair value of warrants issued with the Series A convertible preferred stock (4,688,000) (4,688,000)
Fair value of vested stock options and warrants 2,400,000 2,400,000
Net loss (15,918,000) (15,918,000)
Balance at Dec. 31, 2019 $ 2,000 68,028,000 (56,585,000) 11,445,000
Balance, shares at Dec. 31, 2019 4,396 24,496,197      
Balance at Mar. 31, 2019 $ 1,000 36,590,000 (43,675,000) (7,084,000)
Balance, shares at Mar. 31, 2019 12,344,451      
Balance at Dec. 31, 2019 $ 2,000 68,028,000 (56,585,000) $ 11,445,000
Balance, shares at Dec. 31, 2019 4,396 24,496,197      
Common stock issued upon exercise of options, shares        
Proceeds from sale of common stock $ 1,000 3,429,000 $ 3,430,000
Proceeds from sale of common stock, shares 3,392,833      
Fair value of common stock issued for services 321,000 321,000
Fair value of common stock issued for services, shares 320,601      
Fair value of vested stock options 381,000 381,000
Fair value of vested stock options, shares      
Sale of common stock from private placement $ 1,000 3,429,000 3,430,000
Sale of common stock from private placement, shares 3,392,833      
Fair value of warrants issued to Series A Preferred stockholders (3,951,000) (3,951,000)
Fair value of vested restricted stock awards 241,000 241,000
Fair value of vested restricted stock awards, shares 11,025      
Conversion of convertible debt
Conversion of convertible debt, shares (1,150) 741,933      
Fair value of vested stock options and warrants 3,951,000 3,951,000
Net loss (1,946,000) (1,946,000)
Balance at Mar. 31, 2020 $ 3,000 $ 68,449,000 $ (58,531,000) $ 9,921,000
Balance, shares at Mar. 31, 2020 3,246 28,962,589